Medicine
Signifor 0.6 mg/1 mL injection
Signifor 0.6 mg/1 mL injection is a prescription medicine containing Pasireotide for subcutaneous use, marketed by Recordati Rare Diseases, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 25°C (77°F), excursions permitted to 15°C-30°C (59°F-86°F), protect…
Key facts
- Active ingredient (INN)
- Pasireotide
- Brand
- Signifor
- Strength
- 0.6 mg/1 mL
- Dosage form
- Injection
- Route
- Subcutaneous
- Packs
- 60 package of 1 mL
- Marketing authorisation holder
- Recordati Rare Diseases
- Manufacturer
- Recordati Rare Diseases
- Origin register
- US FDA, United States
- Storage
- Store at 25°C (77°F), excursions permitted to 15°C-30°C (59°F-86°F), protect from light.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- H01CB05 Pasireotide
- HS code (indicative)
- 3004.39Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 14 December 2012
- Identifiers
- RxCUI 1364109, 1364114, 1364116 +3DailyMed set ID a09a25fc-a5a3-0c82-e053-2995a90a5d74NDC 55292-132Application NDA200677
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 60 package in 1 box / 6 ampule in 1 package / 1 mL in 1 ampule | 55292-132-60 | Recordati Rare Diseases | 14 December 2012 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Pasireotide
Clinical summary
Pasireotide is a somatostatin analog indicated for the treatment of patients with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option, among other approved uses. MedsAcross supplies Pasireotide for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about PasireotideFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Signifor LAR prescribing information (Recordati Rare Diseases) · U.S. National Library of Medicine, DailyMed
- Signifor: European public assessment report (EPAR) · European Medicines Agency
Need Signifor 0.6 mg/1 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.